Spotlight On... Researchers create first 3-D 'map' of malaria parasite protein; U.K. meningitis B petition gathers steam; Genetically modified cows could lead to MERS vaccine; and more...

A team of scientists has created the first 3-D "map" of a protein used by malaria parasites to invade human blood cells. This could lead to the development of a vaccine that could attack the most widespread species of the parasite, the Economic Times reported. The "map" shows where the parasite's proteins bind to receptors on red blood cells, allowing the researchers to begin designing inhibitors that could be used in a malaria vaccine. Read more

> A U.K. petition demanding that all children under age 11, not just babies, be vaccinated against meningitis B has acquired more than 750,000 signatures. Story

> A team of scientists has used genetically modified cows to produce antibodies against MERS, which could lead to a vaccine for the disease. More

> University of Tokyo researchers have developed a peptide vaccine that could potentially protect the brain if administered prior to a stroke. Article

Suggested Articles

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan

On the heels of last week's deal for 120 million Pfizer-BioNTech shots, Japan has locked down 120 million more vaccines from AstraZeneca.

The pandemic price could be lowered for larger deals, CEO Stephane Bancel said. Pfizer and BioNTech priced 100M doses at $19.50 each for the U.S.